Andrew C. Bulmer

Associate Professor, Co-lead AVATAR, Group leader Experimental Laboratory Science (XLabS), School of Medical Science, Griffith University, Australia.

[AVATAR Group @AVATAR_grp]

Check out this awesome blog by @TylerBlah007 about cannulation and blood collection in cancer patients https://t.co/BvV7rL71xr

[Andrew C. Bulmer @AndrewBulmer6]

@AVATAR_grp @WendyMoyle2 this is fantastic outcome for #AVATAR_grp researchers and patients - would be wonderful to share this impactful outcome with GU..

[Andrew C. Bulmer @AndrewBulmer6]

@pcarriv You never lose the skill @pcarriv and I count myself incredibly fortunate to have been trained in the art by you! Every cannulation I perform has your signature on it....

[Andrew C. Bulmer @AndrewBulmer6]

The AVATAR group are offering a scholarship to assist prospective students who wish to complete their Master of Medical Research or Doctor of Philosophy at Griffith University. Enquire within! https://t.co/01wAN6Yett @AVATAR_grp @Claire_AVATAR @AVASociety

[Andrew C. Bulmer @AndrewBulmer6]

Bilirubin perturbs mitochondrial function, reducing metabolic efficiency... This likely contributes to lean phenotype in individuals with mildly elevated bilirubin (Gilbert's Syndrome) https://t.co/pRomDfOeVX

[European Journal of Pharmaceutical Sciences @EditorsEJPS]

Biliverdin and bilirubin sulfonate inhibit monosodium urate induced sterile inflammation in the rat. By R. G. Shiels, W. Hewage, E. N. Pennell, J. Vidimce, G. Grant, A. G. Pearson, K. Wagner, M. Morgan, A. C. Bulmer. https://t.co/Yog9fsKWAa

[Andrew C. Bulmer @AndrewBulmer6]

Sage advice here.. it's a 'hard knock life', but it's worth it.

[AVATAR Group @AVATAR_grp]

Confessions from a PhD student, what I wish I knew when I started: https://t.co/a8kYwQHiSh

[Andrew C. Bulmer @AndrewBulmer6]

What a conference... great talks and attendees.. Thanks so much to the conference organisers! @gnljameson

[SFRR-Australasia @SFRRAustralasia]

That's a wrap! Some great presentations from ECRs at our #SFRRA2020 annual meeting! Thanks to #IJMS and #Antioxidants for sponsoring this event! @IJMS_MDPI @antioxidants_OA

[Andrew C. Bulmer @AndrewBulmer6]

Incredibly impactful research published by one of the Society's most respected redox biologists Prof Jiri Neuzil https://t.co/W6X5sDyQcR @SFRRAustralasia #mitochondria #metabolism

[Andrew C. Bulmer @AndrewBulmer6]

@pcarriv @AirliftNurse The ametuer superimposition of individual's faces onto others bodies is a greatly under-utilised in research presentations.

[Andrew C. Bulmer @AndrewBulmer6]

@ISaveThatLine An incredible privilege to make this presentation for our colleagues - enjoy.

[Andrew C. Bulmer @AndrewBulmer6]

@vineet_chopra @a_ullman @AVASociety @AVATAR_grp Not surprised you erred away from slipery and sticky PICCs for this presentation...

[Andrew C. Bulmer @AndrewBulmer6]

Huge thanks and congratulations to @evan_alexandrou, @S2Keogh/ @AVASociety for organising an exceptional conference. Every time I attend, I learn something new and receive valuable lessons about how we can make vascular access complications history. Bravo!

[Andrew C. Bulmer @AndrewBulmer6]

A new route of biliverdin metabolism discovered in mammals, indicating novel anti-inflammatory effects of bile pigments #bilirubiin https://t.co/9jeorxeUsi

[Andrew C. Bulmer @AndrewBulmer6]

@vineet_chopra @UMich Looks like a good time to come to Australia for a break! stay safe!

[Andrew C. Bulmer @AndrewBulmer6]

Improving our knowledge concerning the impact of vascular access device insertion and maintenanc practices on blood vessels is critical to improving device performance and patient outcomes. https://t.co/zV7OnQRcwQ @S2Keogh @AVATAR_grp #XLabS

[Andrew C. Bulmer @AndrewBulmer6]

Revolutionary data that could lead to new treatments for inflammatory diseases.... "Unprecedented Microbial Conversion of Biliverdin into Bilirubin-10-sulfonate" to be published in Scientific Reports! #science #notfakenews #microbiome #bilepigments

[Andrew C. Bulmer @AndrewBulmer6]

Acknowledging the importance of nurses within the development vascular access teams... handsome folks #Flashback @pcarriv @AlexandrouE @AirliftNurse

[AJP-Heart and Circ @ajpheartcirc]

New review by @MenziesHealth researchers discusses our current knowledge of, and uses for, #bilirubin in clinical medicine & summarizes recent progress in revealing the physiological importance of this poorly understood molecule https://t.co/RS4WNMwlyQ

[Andrew C. Bulmer @AndrewBulmer6]

Great pride in what we have built, in such a short time. Welcome #pcarriv to Griffith, #avatargroup and #XLabS. You are a vital component of our multi-disciplinary research group, who seek with AVATAR, to make vascular access complications history.